Safety, Immunogenicity, and Protective Efficacy of Two Regimens of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) During Natural Transmission Season in Healthy African Adults in Mali

NCT03510481 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

478

Enrollment

NIH

Sponsor class

Conditions

Malaria

Interventions

BIOLOGICAL: PfSPZ Vaccine
DRUG: Normal Saline
DRUG: artemether 20mg/lumefantrine 120mg (AL)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]